The 8th ASEAN Medical Device Committee Meeting (AMDN) will take place in Manila from August 4-8, 2019. The meeting will be hosted by the Philippines Association of Medical Device Regulatory Affairs Professionals (PAMDRAP) together with the Philippines Food and Drug Administration (FDA).

Government regulators and technical committee members will gather for closed door meetings.  At the same time, Industry Training Sessions will be held on Wednesday, August 7th and Thursday, August 8th including a Public-Private Forum on Thursday afternoon from 2:00 to 5:30.  The full program will conclude with a Gala Dinner on Thursday evening.

Industry stakeholders are invited to attend the trainings, forum and Gala dinner. Information on registration process and fees are available here: 

Asia Actual personnel will be in attendance and report on significant developments. Contact us to arrange a briefing.


The Philippines FDA intended to implement the first two phases of the new medical device regulatory system (known as Administrative Order 2018-0002) on April 11, 2019, however the implementation date has been delayed.  Extra time is needed for the CDRRHR to finalized guidelines for classification and grouping, etc.

No formal guidance on the new target implementation date has been announced, but it is expected to be several weeks later. In the meantime, the CDRRHR will continue to accept and process Certificate of Product Registration (CPR) and Certificate of Exemption (COE) applications under the current Rules.

Details of the AO 2018-0002 requirements were reported earlier and available on the Asia Actual website here

Asia Actual has a strong regulatory team in Manila to help device manufacturers stay informed and compliant with regulatory changes. Please contact us with questions or support requests.


Today the Philippines FDA provided important guidance related to the new Medical Device Regulations at a public forum held in Manila. The target date for implementation of AO 2018-0002 was announced for April 11, 2019. At that time, Class A, B, C and D medical devices will require a Certificate of Medical Device Notification (CMDN) in order to be imported and placed on the market in the Philippines. The grace period for compliance will be announced in March and expected to be 12 months.

Certificates of Product Registration (CPR) issued under the old Rules will remain valid until expiry at which point a license renewal application will generate a fresh CMDN. Certificates of Exemption (COE) issued under the old Rules will remain valid until an announcement by the FDA. The timing of this announcement has not yet been determined but likely to be several months to 1 year in the future. IVD devices are not affected by the new Rules.

Government processing fee for the CMDN will be based on the old Rules (e.g., US$175 covering five years) at first and then transition to the new risk-based fee structure floated back in July of last year (ref. article available here).

Official processing times will remain at 180 working days due to the high anticipated application volumes, however actual review times should be much faster.

Once implementation is made official, FDA will no longer accept applications for CPR or COE. However, any CPR or COE applications submitted prior to the implementation date will processed as normal.

Implementation of the new Rules is being conducted in phases. These changes represent Phase 0 and Phase 1 of the implementation plan announced in January of last year (copy of document available here ). Timelines for Phase 2 and 3 in which Class B, C and D devices will require the more comprehensive Certificate of Medical Device Registration (CMDR) have not yet been announced.

Important questions remain about classification, grouping, the validity of the products under COE, the management of the new fees, etc. Clarifications on these points are expected in March.

Asia Actual has a strong regulatory team in Manila to help device manufacturers stay informed and compliant with regulatory changes. Please contact us with questions or support requests.

Philippines Proposes New Fees for Medical Device Registration

The Philippines Department of Health published a draft schedule of fees to be charged for medical device registrations under the new Rules next year. As per Administrative Order 2018-0002, medical devices will be classified by increasing risk from A to D. The new registration fees will have three components that vary by risk classification as below:

Classification Type            Application   Evaluation Fee   Annual Retention fee

1.      Class A Notification              PhP 5,000         PhP 10,000             PhP  2,000

2.      Class B Registration            PhP 10,000       PhP 20,000             PhP  5,000

3.      Class C Registration            PhP 15,000       PhP 45,000             PhP  9,000

4.      Class D Registration            PhP 30,000       PhP 60,000             PhP 12,000

While not exorbitant by regional standards, the proposed changes do represent a significant increase in registration costs in the Philippines. Under the old Rules, government fees to process a Certificate of Product Registration (CPR) were PhP 1,500 for the initial application which was valid for 1 year and then PhP 5,000 for the renewal application which was valid for 5 years. By way of comparison, the 5-year regulatory fees for a CPR total about US$140, while the 5-year regulatory fees for a Class C Registration would total US$1,962.

A meeting was held to solicit stakeholder feedback on June 28th. Finalization of the guidance document on fees is expecting in the coming weeks.

Please contact Asia Actual with questions or support requests from our team in Manila.

Philippines Announces New Medical Device Regulations

The Philippines Department of Health has launched new medical device regulations as announced in Administrative Order 2018-0002 dated January 26, 2018. The effective date is expected to be April 1, 2018, fifteen days after publication in two newspapers of general circulation. Medical device manufacturers are advised to take appropriate action to maintain market access for their devices in the Philippines.

The new system will be implemented in phases. At first, all Class A device will be required to obtain a Certificate of Medical Device Notification (CMDN). The same requirement applies to new registration applications for notified devices (those that previously required a Certificate of Product Registration). Manufacturers or their local authorized agents should have a 12-month grace period to comply before losing market access.  All current Certificates of Product Registration (CPR) will remain valid until their expiry date.

Then in Phase 1 implementation of the new requirements, all non-notified Class B, C and D devices will be required to obtain a CMDN. In Phase 2, Class D devices will be required to meet the stricter standards of a Certificate of Product Registration (CMDR). Finally, in Phase 3, all Class B and C devices will be required to obtain a CMDR. No information has yet been released on the timing of these phases.

Technical data requirements for the CMDR are similar to those of the CPR, but data must be formatted as per the ASEAN Common Submission Dossier Template (ACSDT). Another significant change will be to product grouping which is expected to be more generous under ASEAN MDD guidelines. Additionally, the CMDN and CMDR will be valid for 5 years.

Manufacturers are advised to determine the classification of all devices of interest for the Philippines market to confirm which phase will apply to each.

Further guidance is exepected in the coming weeks and more information including a full copy of AO 2018-0002 is available on the Philippines page of the Asia Actual web site.

Please contact us with questions or support requests from our team in Manila.

The Philippines FDA Streamlines Amendment Submission Process

On December 15, 2017 the FDA released guidance that provides for streamlining of the submission process for CPR amendments.

Currently, a single license holder is limited to 5 application submissions per week.  This practice was established so that large license holders would not monopolize CDRRHR resources.

Under the new guidance, qualifying CPR amendment applications can be grouped together in a single submission. For example, a change to the legal manufacturer’s address that applies to 20 CPRs may now be submitted at one time as opposed to over 4 weeks as was previously required.

A copy of Philippines FDA Circular 2017-014 is available at the bottom of the Philippines page of the Asia Actual web site.

Philippines Implements New Customs Clearance Procedure for Radiation Devices

Radiation-emitting medical devices such as X-ray machines, MRIs, linear accelerators and ultrasound scanners are now subject to a new customs clearance release procedure administered by the Philippine FDA. The new procedure, announced through FDA Circular 2017-013 on November 16, 2017, with immediate effect, replaces a similar process overseen by the Bureau of Customs.

For each shipment, importers of radiation-emitting devices must obtain a Clearance for Customs Release (CFCR) certificate issued by the FDA’s Center for Device Regulation, Radiation Health, and Research (CDRRHR). Applications will be processed within 3 working days for a fee of US$6 (Philippine Peso 300) per device.

One of the required elements of the CFCR application is a certificate of product registration issued by the national authority in the country of origin.  This document must be Authenticated by the Philippines embassy in the country of origin. Sufficient time should be allocated to fulfill this requirement.

A copy of FDA Circular 2017-013 is available at the bottom of the Philippines market page on Asia Actual’s website.


With FDA Advisory No. 2017-180 issued on June 20, 2017 the Philippines government announced intentions to gradually switch to power-free gloves.  A full ban of powdered surgical and examination glove will go into effect on January 1, 2019 effecting the importation, distribution and sale of specified devices.

This action comes in follow up to an FDA Advisory from earlier in the year outlining the risk associated with powered gloves.

A copy of FDA Advisory No. 2017-180 is available on the Philippines page of the Asia Actual website.

The Philippines FDA Publishes New Guidance on Medical Device Recalls

The Philippines FDA has published a Circular clarifying medical device recall requirements referenced in sections 5 (k) of the FDA Act of 2009. The requirements will go into effect in September of 2016.

The Circular provides guidance on how to conduct a recall in the Philippines and criteria for recall triggers. Also included is information on the composition and responsibilities of the Product Recall Committee and Market Authorization Holder.

Other steps toward harmonization are expected early in the new year.

A copy of the full FDA Circular 2016-012 is available here.

The Philippines FDA No Longer Requires Physical Samples for Medical Device Registration

Product samples are no longer required for The Philippines medical device registration process as part of the application requirements. Adequate pictures or line drawings may be used in lieu of physical specimens for registration. This change streamlines the application process by eliminating the need to import an unregistered medical device.

Details available here.